News

Nearly half of Gen Zers (45%) lack a good understanding of the factors that affect their credit score, with roughly 1 in 5 ...
HistoSonics, founded in 2009, received FDA De Novo clearance in October 2023 and uses non-invasive focused ultrasound energy to mechanically destroy and liquify targeted tissue and tumors at a ...